eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 12 | +12 |
| Shares | 0 | 13.4M | +13.4M |
| Value | $0 | $187.9M | +$187.9M |
New holders (12)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Abingworth LLP | 4,822,114 | $67.0M | 15.21% |
| The Column Group LLC | 4,309,329 | $60.5M | 6.89% |
| Sectoral Asset Management Inc | 2,882,744 | $40.5M | 3.37% |
| Blackstone Group Inc. | 1,308,587 | $18.4M | 0.04% |
| Verition Fund Management LLC | 24,667 | $347.0K | 0.01% |
| Geode Capital Management, LLC | 24,005 | $337.0K | 0.00% |
| Jane Street Group, LLC | 18,304 | $257.0K | 0.00% |
| Virtu Financial LLC | 17,444 | $245.0K | 0.02% |
| Citadel Advisors LLC | 13,277 | $187.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 6,859 | $97.0K | 0.00% |
| Creative Financial Designs Inc | 430 | $6.00K | 0.00% |
| Morgan Stanley | 100 | $1.00K | 0.00% |
Sold out (0)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.